Filing Details

Accession Number:
0001209191-18-017179
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-06 15:22:43
Reporting Period:
2018-03-05
Accepted Time:
2018-03-06 15:22:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
19411 Magellan Health Inc MGLN Services-Hospitals (8060) 581076937
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1184746 N Daniel Gregoire 55 Nod Road
Avon CT 06001
General Counsel And Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Common Stock, $0.01 Par Value Acquisiton 2018-03-05 12,538 $63.95 25,995 No 4 X Direct
Ordinary Common Stock, $0.01 Par Value Acquisiton 2018-03-05 5,042 $64.87 31,037 No 4 X Direct
Ordinary Common Stock, $0.01 Par Value Acquisiton 2018-03-05 5,295 $68.50 36,332 No 4 X Direct
Ordinary Common Stock, $0.01 Par Value Disposition 2018-03-05 22,875 $99.05 13,457 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Direct
No 4 X Direct
No 4 X Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (right to buy) Disposition 2018-03-05 12,538 $0.00 12,538 $63.95
Common Stock Stock Options (right to buy) Disposition 2018-03-05 5,042 $0.00 5,042 $64.87
Common Stock Stock Options (right to buy) Disposition 2018-03-05 5,295 $0.00 5,295 $68.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-03-04 No 4 X Direct
5,041 2026-03-03 No 4 X Direct
10,590 2027-03-03 No 4 X Direct
Footnotes
  1. This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
  2. The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $98.75 to $99.25, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
  3. All of the stock options in this tranche have vested in full.
  4. Not applicable.
  5. The remainder of 5,041 options shall vest on March 3, 2019.
  6. The remainder of 10,590 options shall vest in equal increments on each of March 3 of 2019 and 2020.